These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 22644852)
1. Localized delivery of cisplatin for the effective management of squamous cell carcinoma from protransfersome formulation. Gupta V; Karthikeyan C; Trivedi P Arch Pharm Res; 2012 May; 35(5):851-9. PubMed ID: 22644852 [TBL] [Abstract][Full Text] [Related]
2. Reduction in cisplatin genotoxicity (micronucleus formation) in non target cells of mice by protransfersome gel formulation used for management of cutaneous squamous cell carcinoma. Gupta V; Agrawal RC; Trivedi P Acta Pharm; 2011 Mar; 61(1):63-71. PubMed ID: 21406344 [TBL] [Abstract][Full Text] [Related]
3. Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancy. Gupta V; Dhote V; Paul BN; Trivedi P J Liposome Res; 2014 Jun; 24(2):150-62. PubMed ID: 24328725 [TBL] [Abstract][Full Text] [Related]
4. Topical delivery of fluorescence (6-Cf) labeled and radiolabeled (99m-Tc) cisplatin and imiquimod by a dual drug delivery system. Gupta V; Chuttani K; Mishra AK; Trivedi P J Labelled Comp Radiopharm; 2014 May; 57(6):425-33. PubMed ID: 24889134 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies. Gupta V; Trivedi P Artif Cells Nanomed Biotechnol; 2015; 43(6):373-82. PubMed ID: 24628359 [TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis. Pople PV; Singh KK Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619 [TBL] [Abstract][Full Text] [Related]
7. Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. Hiruta Y; Hattori Y; Kawano K; Obata Y; Maitani Y J Control Release; 2006 Jun; 113(2):146-54. PubMed ID: 16793162 [TBL] [Abstract][Full Text] [Related]
8. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug. Bodade SS; Shaikh KS; Kamble MS; Chaudhari PD Drug Deliv; 2013; 20(1):40-6. PubMed ID: 23311652 [TBL] [Abstract][Full Text] [Related]
9. Lipid vesicles and other colloids as drug carriers on the skin. Cevc G Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752 [TBL] [Abstract][Full Text] [Related]
10. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Panchagnula R; Bokalial R; Sharma P; Khandavilli S Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059 [TBL] [Abstract][Full Text] [Related]
11. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. Bhatia A; Kumar R; Katare OP J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model. Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659 [TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus. Pople PV; Singh KK Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. Paolino D; Celia C; Trapasso E; Cilurzo F; Fresta M Eur J Pharm Biopharm; 2012 May; 81(1):102-12. PubMed ID: 22414731 [TBL] [Abstract][Full Text] [Related]
15. Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential. Zhang Y; Jing Q; Hu H; He Z; Wu T; Guo T; Feng N Int J Pharm; 2020 Apr; 580():119183. PubMed ID: 32112930 [TBL] [Abstract][Full Text] [Related]
16. Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation. Xi H; Yang Y; Zhao D; Fang L; Sun L; Mu L; Liu J; Zhao N; Zhao Y; Zheng N; He Z Int J Pharm; 2010 May; 391(1-2):73-8. PubMed ID: 20170718 [TBL] [Abstract][Full Text] [Related]
17. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226 [TBL] [Abstract][Full Text] [Related]
18. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study. González-Paredes A; Manconi M; Caddeo C; Ramos-Cormenzana A; Monteoliva-Sánchez M; Fadda AM J Liposome Res; 2010 Dec; 20(4):269-76. PubMed ID: 19954402 [TBL] [Abstract][Full Text] [Related]
19. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Mura S; Manconi M; Sinico C; Valenti D; Fadda AM Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377 [TBL] [Abstract][Full Text] [Related]
20. Transcutol containing vesicles for topical delivery of minoxidil. Mura S; Manconi M; Valenti D; Sinico C; Vila AO; Fadda AM J Drug Target; 2011 Apr; 19(3):189-96. PubMed ID: 20446805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]